Come up with a name for your new list and we'll add to it:
DiamiR raised a round of funding on March 16, 2015. Investors include
National Institutes of Health.
DiamiR is a privately held molecular diagnostic company focused on developing noninvasive tests for early detection and monitoring of Mild Cognitive Impairment, Alzheimer's disease, other neurodegener…